Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers

Nadine Houédé; Philippe Pourquier

doi:10.1016/j.pharmthera.2014.06.004

Journal Articles Alimentary Pharmacology & Therapeutics (Suppl) Year : 2015

Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers

(1) , (2)

1
2

Nadine Houédé

Function : Author
PersonId : 757627
ORCID : 0000-0002-8852-5754

Centre Hospitalier Universitaire de Nîmes

Philippe Pourquier

Function : Author
PersonId : 181384
IdHAL : philippe-pourquier
ORCID : 0000-0001-5326-3005
IdRef : 087256452

Signalisation et Mecanismes Moleculaires de l'Apoptose

Domains

Life Sciences [q-bio]

Philippe Pourquier : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02438837

Submitted on : Tuesday, January 14, 2020-1:30:52 PM

Last modification on : Friday, June 12, 2020-4:58:20 PM

Dates and versions

inserm-02438837 , version 1 (14-01-2020)

Identifiers

HAL Id : inserm-02438837 , version 1
DOI : 10.1016/j.pharmthera.2014.06.004

Cite

Nadine Houédé, Philippe Pourquier. Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers. Alimentary Pharmacology & Therapeutics (Suppl), 2015, 145, pp.1-18. ⟨10.1016/j.pharmthera.2014.06.004⟩. ⟨inserm-02438837⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM

16 View

0 Download

Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share